glp-1 intracranial hypertension Exenatide (a receptor agonist) rapidly lowered pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP-lowering mechanism beyond weight Health Needs_Gut Health glp-1 and protein intake Size:30 Meals

glp-1 intracranial hypertension Exenatide (a receptor agonist) rapidly lowered pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP-lowering mechanism beyond weight Health Needs_Gut Health glp-1 and protein intake Size:30 Meals

glp-1 and protein intake Stop overcomplicating your on 🥩 Spending your entire Sunday meal prepping

Degradation was slower than for hGLP-1 but clearly measurable, with less than 50% uncleaved pGLP-1 and eGLP-1 remaining after 11 hours of incubation (Table 1)

Health Needs_Gut Health

Size:30 Meals

Fast forward to today, and GLP-1 receptor agonists, originally developed for diabetes, have proven their worth in inducing significant weight loss with mostly manageable side effects